• ABSORB Japan interview with Ken Kozuma

    Dr. Ron Waksman interviews Dr. Ken Kozuma on the ABSORB Japan: 3-year clinical and angiographic results of a randomised trial evaluating the Absorb bioresorbable vascular scaffold vs. metallic DES in de novo native coronary artery lesions

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details